EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Small‐Molecule Targeting MuRF1 Protects Against Denervation‐Induced Diaphragmatic Dysfunction: Underlying Molecular Mechanisms

Fernando Ribeiro, Paulo R Jannig, Siegfried Labeit, Anselmo S Moriscot iD

Journal of Cachexia, Sarcopenia and Muscle · 2025-12 · 16 (6)

DOI: 10.1002/jcsm.70119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, online erschienen am 16.11.2025. Verfasst von Fernando Ribeiro und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Diaphragm, Tripartite Motif Proteins, Ubiquitin-Protein Ligases, Muscle Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: São Paulo Research Foundation, National Council for Scientific and Technological Development, Karolinska Institutet (KI) Research Foundation Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mechanical inactivity rapidly induces diaphragm muscle fibres' contractile dysfunction and atrophy. Diaphragm weakness can impair respiratory function, quality of life and increase risks of morbidity and mortality. Muscle RING‐finger protein‐1 (MuRF1) expression is upregulated during denervation and muscle inactivity and is known to target key muscle proteins for degradation. We previously reported that the small‐molecule targeting MuRF1 (MyoMed‐205) protects against diaphragm contractile dysfunction and atrophy after 12 h of unilateral diaphragm denervation (UDD) in rats. In this study, we investigated the mechanisms by which MyoMed‐205 protects the diaphragm structure and function during early UDD in rats.

Methods

Male Wistar rats were subjected to unilateral diaphragm denervation (UDD) for 12 h. Immediately after UDD, rats received either a placebo (vehicle) or small‐molecule targeting MuRF1 (MyoMed‐205, 50 mg/kg bw), and outcomes were compared with sham‐operated controls. Diaphragm was used for histological, morphometric, transcriptomic (RNA‐seq) and protein content (Western blot) analysis.

Results

UDD induced diaphragm slow‐ (Type I: p = 0.03) and fast‐twitch (Type IIa: p = 0.04; Type IIb/x: p = 0.02) fibres atrophy after 12 h, which was prevented by MyoMed‐205 ( p < 0.05). Mechanistically, UDD perturbed mechanisms involved with myofibre ultrastructure and contractility, mitochondrial function, proteolysis and tissue remodelling in the diaphragm. MyoMed‐205 enhanced the activation of mechanisms required for sarcomere integrity, calcium handling, antioxidant defence, chaperone‐mediated unfolded protein response and muscle growth. MyoMed‐205 also mitigated intramuscular fat deposition and pro‐fibrotic responses triggered by UDD.

Conclusions

Small‐molecule targeting MuRF1 (MyoMed‐205) protects against diaphragm muscle contractile dysfunction and atrophy after 12 h of UDD. Herein, we demonstrate that this protective effect involved augmented activation of signalling pathways controlling muscle structure and function, chaperone‐mediated unfolded protein and muscle growth, while mitigating intramuscular fat deposition and pro‐fibrotic responses triggered by UDD at the transcriptional and/or protein level.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DiaphragmTripartite Motif ProteinsUbiquitin-Protein LigasesMuscle ProteinsAnimalsRatsMaleRats, WistarMuscular AtrophyMuscle Contraction

Stichwörter der Autor:innen

MyoMed‐205PI3K‐Akt–mTOR pathwayTRIM63mechanical unloadingskeletal muscleubiquitin‐proteasome systemunilateral diaphragm denervation

Substanzen

Tripartite Motif ProteinsUbiquitin-Protein LigasesMuscle ProteinsTrim63 protein, rat

Autor:innen und Institutionen

  • Department of Anatomy, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
  • Department of Physiology and Pharmacology, Biomedicum, Karolinska Institutet, Stockholm, Sweden.
  • Department for Integrative Pathophysiology, DZHK Partner Site Mannheim-Heidelberg, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Myomedix GmbH, Neckargemünd, Germany.

ORCID-Profile: Anselmo S Moriscot

Förderung

  • São Paulo Research Foundation
  • National Council for Scientific and Technological Development
  • Karolinska Institutet (KI) Research Foundation Grant
  • German Centre for Cardiovascular Research (DZHK) partner site Mannheim-Heidelberg
  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Ribeiro, F., Jannig, P. R., Labeit, S., & Moriscot, A. S. (2025). Small‐Molecule Targeting MuRF1 Protects Against Denervation‐Induced Diaphragmatic Dysfunction: Underlying Molecular Mechanisms. Journal of Cachexia, Sarcopenia and Muscle, 16(6). https://doi.org/10.1002/jcsm.70119

Vancouver

Ribeiro F, Jannig PR, Labeit S, Moriscot AS. Small‐Molecule Targeting MuRF1 Protects Against Denervation‐Induced Diaphragmatic Dysfunction: Underlying Molecular Mechanisms. Journal of Cachexia, Sarcopenia and Muscle. 2025;16(6). doi:10.1002/jcsm.70119

BibTeX
@article{Ribeiro2025,
  author = {Ribeiro, Fernando and Jannig, Paulo R and Labeit, Siegfried and Moriscot, Anselmo S},
  title = {Small‐Molecule Targeting MuRF1 Protects Against Denervation‐Induced Diaphragmatic Dysfunction: Underlying Molecular Mechanisms},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2025},
  volume = {16},
  number = {6},
  doi = {10.1002/jcsm.70119}
}
Kostenlos starten →